Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: Implications for tumor angiogenesis

Studies aimed at elucidating the function of the protein synthesis factor eukaryotic initiation factor 4E (elF‐4E) have demonstrated that overexpression of this protein results in marked cell phenotypic and proliferative changes, including neoplastic transformation of cells. These data suggest that elF‐4E may somehow participate in the development and progression of tumors in vivo. In order to determine how elF‐4E exerts its transforming effects, we examined vascular permeability factor (VPF) levels in cells transfected with an elF‐4E vector. Cells overexpressing elF‐4E showed an increase in intracellular, and an average 130‐fold increase in secreted VPF protein levels (CHO 0.13 ± 0.12 ng/ml; CHO‐4E 20.5 ± 12.5 ng/ml) over control cells. HUVEC growth induction revealed these VPF levels to be biologically active. Northern analysis revealed no difference in VPF transcript between the 2 cell lines. Polysome analysis showed that the VPF message in elF‐4E‐transfected cells was associated with the heavy polysomal regions, whereas the VPF message was associated with light polysomes in control cells. These data strongly suggest that enhanced VPF expression is achieved through translational regulation rather than transcriptional regulation in cells overexpressing elF‐4E. This indicates that elF‐4E‐induced VPF expression may be an important factor in some forms of tumor angiogenesis and development. © 1996 Wiley‐Liss, Inc.

[1]  C. Kevil,et al.  Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. , 1995, Oncogene.

[2]  J. Pouysségur,et al.  Cytoplasmic Domain of the Ubiquitous Na+/H+ Exchanger NHE1 Can Confer Ca2+ Responsiveness to the Apical Isoform NHE3 (*) , 1995, The Journal of Biological Chemistry.

[3]  G. Breier,et al.  Hypoxia-induced Transcriptional Activation and Increased mRNA Stability of Vascular Endothelial Growth Factor in C6 Glioma Cells (*) , 1995, The Journal of Biological Chemistry.

[4]  D. Shima,et al.  Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability , 1995, FEBS letters.

[5]  Y. Miyagi,et al.  Elevated levels of eukaryotic translation initiation factor eIF-4E, mRNA in a broad spectrum of transformed cell lines. , 1995, Cancer letters.

[6]  A. De Benedetti,et al.  The proto‐oncogene/translation factor eIF4E: A survey of its expression in breast carcinomas , 1995, International journal of cancer.

[7]  D. Ruiter,et al.  The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis. , 1995, Biological chemistry Hoppe-Seyler.

[8]  G. Breier,et al.  Hypoxia and platelet‐derived growth factor‐BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells , 1995, FEBS letters.

[9]  J. Folkman,et al.  Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[10]  H. Dvorak,et al.  Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. , 1993, Cancer research.

[11]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[12]  B. Berse,et al.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. , 1992, Molecular biology of the cell.

[13]  A. De Benedetti,et al.  Expression of antisense RNA against initiation factor eIF-4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF-4E and the p220 component of eIF-4F , 1991, Molecular and cellular biology.

[14]  J. Fiddes,et al.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.

[15]  A. De Benedetti,et al.  Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  G. Conn,et al.  Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Dvorak,et al.  A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. , 1986, Cancer research.

[18]  John W. B. Hershey.  Expression of initiation factor genes in mammalian cells. , 1994, Biochimie.

[19]  N. Sonenberg.  Regulation of translation and cell growth by eIF-4E. , 1994, Biochimie.

[20]  J. Winer,et al.  Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. , 1993, The Journal of clinical investigation.